Efficacy and Safety of Once-Weekly Thyroxine for Thyroxine-Resistant Hypothyroidism

CONTEXT: Noncompliance with thyroxine therapy is the most common cause of poor control of hypothyroidism. An open-label prospective study to compare once-weekly thyroxine (OWT) with standard daily thyroxine (SDT) was undertaken. DESIGN: Patients taking thyroxine doses of >3 μg/kg/d, with or witho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Jayakumari, Chellama, Nair, Abilash, Puthiyaveettil Khadar, Jabbar, Das, Darvin V, Prasad, Nandini, Jessy, S J, Gopi, Anjana, Guruprasad, Padmanabhan
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Clinical Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6834071/
https://ncbi.nlm.nih.gov/pubmed/31723717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00212
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars